Ardelyx
Fremont, US
Biotech
Founders & leadership
AG
Annalisa G. JenkinsDirector
MG
Mark G. KaufmannExecutive Officer
EG
Elizabeth G. GrammerExecutive Officer
RG
Richard G. RodgersDirector
GG
Gordon G. RingoldDirector
PG
Peter G. SchultzDirector
DM
David MottDirector
DG
David G. RosenbaumExecutive Officer
JG
Jeremy G. CaldwellExecutive Officer
MR
Michael RaabExecutive Officer, Director
Reported raises · per SEC filings
Form D private placements$110MraisedAug 2016 · 31 investors · Pharmaceuticals
Rule 506(b)$77.8MraisedJun 2015 · 11 investors · Pharmaceuticals
Rule 506(b)Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.